Dr. Alonso-Llamazares is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
475 Biltmore Way
Ste 308
Coconut Grove, FL 33134Phone+1 305-443-2994Fax+1 305-443-9725
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 2003 - 2006- Mayo Clinic College of Medicine and Science (Rochester)Internship, Internal Medicine, 2002 - 2003
Universidad de Navarra Faculty of MedicineClass of 1989
Certifications & Licensure
FL State Medical License 2006 - 2027
American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- DFD06 Cream vs Clobetasol Propionate Cream, 0.05% Hypothalamic- Pituitary-Adrenal (HPA) Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis Start of enrollment: 2014 May 08
- A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis Start of enrollment: 2015 Dec 01
- Study of Glycopyrronium in Axillary Hyperhydrosis Start of enrollment: 2015 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 5 citationsRoflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.Eric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, Zoe D Draelos, Laura K Ferris
JAMA Dermatology. 2024-11-01 - 2 citationsLong-term safety and effectiveness of roflumilast cream 0.3% in adults with chronic plaque psoriasis: A 52-week, phase 2, open-label trial.Linda Stein Gold, David N Adam, Lorne Albrecht, Javier Alonso-Llamazares, Laura K Ferris
Journal of the American Academy of Dermatology. 2024-08-01 - 16 citationsRoflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.Andrew Blauvelt, Zoe D Draelos, Linda Stein Gold, Javier Alonso-Llamazares, Neal Bhatia
Journal of the American Academy of Dermatology. 2024-05-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
